SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL
Delisted
SEEL was delisted on the 15th of October, 2024.
92 hedge funds and large institutions have $108M invested in Seelos Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% less capital invested
Capital invested by funds: $125M → $108M (-$17.1M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
92
Holding in Top 10
1
Calls
$1.97M
Puts
$1.42M
Top Buyers
| 1 | +$10.9M | |
| 2 | +$6.16M | |
| 3 | +$4.96M | |
| 4 |
JGC
J. Goldman & Co
New York
|
+$4.85M |
| 5 |
Two Sigma Investments
New York
|
+$4.76M |
Top Sellers
| 1 | -$9.69M | |
| 2 | -$7.22M | |
| 3 | -$3.05M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$3.04M |
| 5 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$2.2M |